Sign in

CIK 0001813814

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Definium Therapeutics, Inc.

Sign in to watch
Ticker
DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 212-220-6633
Business address
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
Former names
Mind Medicine (MindMed) Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,023,010
in 6 filings, $3.0M under 10b5-1 plans

Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-25 Roberts Brandi Chief Financial Officer Sale 10b5-1 −3,377 $36.57 $123K 394,528
2026-09-14 Roberts Brandi Chief Financial Officer Grant or award +125,000 397,905
2026-08-12 Roberts Brandi Chief Financial Officer Grant or award +62,500 271,987
2026-06-25 Roberts Brandi Chief Financial Officer Sale 10b5-1 −3,013 $45.03 $136K 209,487
2026-06-22 Roberts Brandi Chief Financial Officer Grant or award +62,500 212,500
2026-02-03 Roberts Brandi Chief Financial Officer Grant or award +150,000 150,000
2025-06-02 Roberts Brandi Chief Financial Officer Grant or award · Stock Option (Right to Buy) +500,000 500,000

Page 1 of 1 · 7 trades